The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 Update on Recent Developments in AML - CX-01, HuF59 Anti-CD47 Antibody, Ivosidenib + Azacitidine

186 views
August 19, 2019
0 Comments
Login to view comments. Click here to Login
Hematologic Malignancies